Endocrine-disrupting chemicals (EDCs): In Vitro mechanism of estrogenic activation and differential effects on ER target genes

Environmental Health Perspectives

Volumn 121, Issue 4, 2013, Pages 459-466

  Li, Yin ^a   Luh, Colin J ^a   Burns, Katherine A ^a   Arao, Yukitomo ^a   Jiang, Zhongliang ^a   Teng, Christina T ^a   Tice, Raymond R ^a   Korach, Kenneth S ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

E2; EDCs; ER target genes; ER ; ER ; ERE

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CHLORDECONE; COUMESTROL; DAIDZEIN; ENDOCRINE DISRUPTOR; ENDOSULFAN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FLAVONOID; GENISTEIN; ISOFLAVONE; KAEMPFEROL; LUCIFERASE;

ARTICLE; CONTROLLED STUDY; ENZYME MECHANISM; ESTROGEN ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TRANSIENT TRANSFECTION;

CELL LINE, TUMOR; ENDOCRINE DISRUPTORS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HELA CELLS; HEP G2 CELLS; HUMANS; LUCIFERASES; MALE; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84875892870     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1205951     Document Type: Article

References (46)

1. Akahori Y, Nakai M, Yamasaki K, Takatsuki M, Shimohigashi Y, Ohtaki M. 2008. Relationship between the results of in vitro receptor binding assay to human estrogen receptor α and in vivo uterotrophic assay: comparative study with 65 selected chemicals. Toxicol In Vitro 22(1):225-231.
2. Anderson SE, Munson AE, Butterworth LF, Germolec D, Morgan DL, Roycroft JA, et al. 2010. Whole-body inhalation exposure to 1-bromopropane suppresses the IgM response to sheep red blood cells in female B6C3F1 mice and Fisher 344/N rats. Inhal Toxicol 22(2):125-132.
3. Berry M, Nunez AM, Chambon P. 1989. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc Natl Acad Sci USA 86(4):1218-1222.
4. Björnström L, Sjöberg M. 2005. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 19(4):833-842.
5. Borgeest C, Greenfeld C, Tomic D, Flaws JA. 2002. The effects of endocrine disrupting chemicals on the ovary. Front Biosci 7:d1941-d1948.
6. Burns KA, Li Y, Arao Y, Petrovich RM, Korach KS. 2011. Selective mutations in estrogen receptor α D2011;domain alters nuclear translocation and non-estrogen response element gene regulatory mechanisms. J Biol Chem 286(14):12640-12649.
7. Calderón-Montaño JM, Burgos-Morón E, Pérez-Guerrero C, López-Lázaro M. 2011. A review on the dietary flavonoid kaempferol. Mini Rev Med Chem 11(4):298-344.
8. Dang ZC. 2009. Dose-dependent effects of soy phyto-oestrogen genistein on adipocytes: mechanisms of action. Obes Rev 10(3):342-349.
9. waf1/cip1 promoter by Sp1. Cancer Res 64(2):743-750.
10. Dhar K, Banerjee S, Dhar G, Sengupta K, Banerjee SK. 2007. Insulin-like growth factor-1 (IGF-1) induces WISP-2/CCN5 via multiple molecular cross-talks and is essential for mitogenic switch by IGF-1 axis in estrogen receptor-positive breast tumor cells. Cancer Res 67(4):1520-1526.
11. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, et al. 2009. Endocrine-disrupting chemi cals: an Endocrine Society scientific statement. Endocr Rev 30(4):293-342.
12. Ferreira CV, Justo GZ, Souza AC, Queiroz KC, Zambuzzi WF, Aoyama H, et al. 2006. Natural compounds as a source of protein tyrosine phosphatase inhibitors: application to the rational design of small-molecule derivatives. Biochimie 88(12):1859-1873.
13. Guenther K, Heinke V, Thiele B, Kleist E, Prast H, Raecker T. 2002. Endocrine disrupting nonylphenols are ubiquitous in food. Environ Sci Technol 36(8):1676-1680.
14. Hall JM, Korach KS. 2012. Endocrine disrupting chemicals promote the growth of ovarian cancer cells via the ER-CXCL12-CXCR4 signaling axis. Mol Carcinog; doi:10.1002/ mc.21913 [Online 30 April 2012].
15. Hall JM, McDonnell DP. 2005. Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting. Mol Interventions 5(6):343-357.
16. Hall JM, McDonnell DP, Korach KS. 2002. Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements. Mol Endocrinol 16(3):469-486.
17. Henley DV, Korach KS. 2010. Physiological effects and mechanisms of action of endocrine disrupting chemicals that alter estrogen signaling. Hormones (Athens) 9(3):191-205.
18. Henley DV, Mueller S, Korach KS. 2009. The short-chain fatty acid methoxyacetic acid disrupts endogenous estrogen receptor-α-mediated signaling. Environ Health Perspect 117:1702-1706.
19. Hewitt SC, Korach KS. 2011. Estrogenic activity of bisphenol A and 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane (HPTE) demonstrated in mouse uterine gene profiles. Environ Health Perspect 119:63-70.
20. Hwang CS, Kwak HS, Lim HJ, Lee SH, Kang YS, Choe TB, et al. 2006. Isoflavone metabolites and their in vitro dual functions: they can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J Steroid Biochem Mol Biol 101(4-5): 246-253.
21. Jakacka M, Ito M, Weiss J, Chien PY, Gehm BD, Jameson JL. 2001. Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. J Biol Chem 276(17):13615-13621.
22. Katzenellenbogen BS. 1996. Estrogen receptors: bioactivities and interactions with cell signaling pathways. Biol Reprod 54(2):287-293.
23. Katzenellenbogen BS. 2000. Mechanisms of action and crosstalk between estrogen receptor and progesterone receptor pathways. J Soc Gynecol Investig 7(1 suppl):S33-S37.
24. Katzenellenbogen BS, Montano MM, Ekena K, Herman ME, McInerney EM. 1997. William L. McGuire Memorial Lecture. Antiestrogens: mechanisms of action and resistance in breast cancer. Breast Cancer Res Treat 44(1):23-38.
25. Klotz DM, Hewitt SC, Korach KS, Diaugustine RP. 2000. Activation of a uterine insulin-like growth factor I signaling pathway by clinical and environmental estrogens: requirement of estrogen receptor-α. Endocrinology 141(9):3430-3439.
26. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, et al. 1998. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139(10):4252-4263.
27. Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, et al. 2000. Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 74(5):311-317.
28. Li Y, Burns KA, Arao Y, Luh CJ, Korach KS. 2012. Differential estrogenic actions of endocrine-disrupting chemicals bisphenol A, bisphenol AF and zearalenone through estrogen receptor α and β in vitro. Environ Health Perspect 120:1029-1035.
29. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O. 1993. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 90(23):11162-11166.
30. Markaverich BM, Webb B, Densmore CL, Gregory RR. 1995. Effects of coumestrol on estrogen receptor function and uterine growth in ovariectomized rats. Environ Health Perspect 103:574-581.
31. Matsushima A, Kakuta Y, Teramoto T, Koshiba T, Liu X, Okada H, et al. 2007. Structural evidence for endocrine disruptor bisphenol A binding to human nuclear receptor ERR. J Biochem 142(4):517-524.
32. Matsushima A, Liu X, Okada H, Shimohigashi M, Shimohigashi Y. 2010. Bisphenol AF is a full agonist for the estrogen receptor ERα but a highly specific antagonist for ERβ. Environ Health Perspect 118:1267-1272.
33. McDonnell DP, Norris JD. 2002. Connections and regulation of the human estrogen receptor. Science 296(5573):1642-1644.
34. Mueller SO, Hall JM, Swope DL, Pedersen LC, Korach KS. 2003. Molecular determinants of the stereoselectivity of agonist activity of estrogen receptors (ER) α and β. J Biol Chem 278(14):12255-12262.
35. Murray TJ, Lea RG, Abramovich DR, Haites NE, Fowler PA. 2001. Endocrine disrupting chemicals: effects on human male reproductive health. Early Pregnancy 5(2):80-112.
36. Nilsson S, Mäkelä S, Treuter E, Tujague M, Thomsen J, Andersson G, et al. 2001. Mechanisms of estrogen action. Physiol Rev 81(4):1535-1565.
37. O'Lone R, Frith MC, Karlsson EK, Hansen U. 2004. Genomic targets of nuclear estrogen receptors. Mol Endocrinol 18(8):1859-1875.
38. Perez P, Pulgar R, Olea-Serrano F, Villalobos M, Rivas A, Metzler M, et al. 1998. The estrogenicity of bisphenol A-related diphenylalkanes with various substituents at the central carbon and the hydroxy groups. Environ Health Perspect 106:167-174.
39. Pettersson K, Gustafsson JA. 2001. Role of estrogen receptor beta in estrogen action. Annu Rev Physiol 63:165-192.
40. Reid G, Métivier R, Lin CY, Denger S, Ibberson D, Ivacevic T, et al. 2005. Multiple mechanisms induce transcriptional silencing of a subset of genes, including oestrogen receptor α, in response to deacetylase inhibition by valproic acid and trichostatin A. Oncogene 24(31):4894-4907.
41. Sharma SC, Richards JS. 2000. Regulation of AP1 (Jun/Fos) factor expression and activation in ovarian granulose cells. Relation of JunD and Fra2 to terminal differentiation. J Biol Chem 275(43):33718-33728.
42. van Lipzig MM, ter Laak AM, Jongejan A, Vermeulen NP, Wamelink M, Geerke D, et al. 2004. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method. J Med Chem 47(4):1018-1030.
43. Webb P, Lopez GN, Uht RM, Kushner PJ. 1995. Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 9(4):443-456.
44. Welshons WV, Nagel SC, vom Saal FS. 2006. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147(6 suppl):S56-S69.
45. Wetherill YB, Akingbemi BT, Kanno J, McLachlan JA, Nadal A, Sonnenschein C, et al. 2007. In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 24(2):178-198.
46. Ying GG, Williams B, Kookana R. 2002. Environmental fate of alkylphenols and alkylphenol ethoxylates-a review. Environ Int 28(3):215-22.